Listen Now

Topics Covered

  • The Treatment of Triple Negative Breast Cancer, in the Context of COVID-19
  • Why Clinical Trials Are Important as a Treatment Option for Triple Negative Breast Cancer
  • What Happens in a Clinical Trial
  • New Research in the Treatment of Triple Negative Breast Cancer (TNBC)
  • Investigational New Drugs in Clinical Trials
  • The Meaning of Informed Consent
  • Benefits & Risks of Participation
  • How & Where Clinical Trials are Conducted
  • How to Participate in Clinical Trials
  • Specific Questions to Ask Your Health Care Team about Clinical Trials
  • Accessing Resources for Clinical Trials
  • Questions for Our Panel of Experts

Our Panel of Experts

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Minetta C. Liu, MD

Professor and Research Chair, Division of Medical Oncology, Department of Oncology, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Medical Director, Office of Specialty Collaborations and Contracts, Co-Leader, Genomics in Action Strategic Priority, Center for Individualized Medicine, Mayo Clinic

Elizabeth Jane Cathcart-Rake, MD

Staff Physician, Hematology/Oncology, Saint Luke’s Cancer Specialist in Breast Cancer, Saint Luke’s Cancer Institute

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation®

Ricki Fairley

Vice President, Strategic Partnerships and National Programs, Sisters Network® Inc. – A National African American Breast Cancer Survivorship Network

Lauren Chatalian, MSW

Women and Children's Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(119 KB)

Workshop Date

This workshop was originally recorded on June 17, 2020.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.